Related stories
Bathurst Resources Reports FY27 YTD EBITDA of NZ$9 Million, Issues FY27 EBITDA Guidance
Bathurst Resources reported consolidated FY27 year-to-date EBITDA of NZ$9 million and FY27 EBITDA guidance of NZ$30–$40 million.
M impact | EARNINGS | Oct 29, 2026, 11:45 PM UTC
Vale's Third-Quarter Net Profit Falls 53%
Vale said net profit fell 53% in the third quarter, citing lower iron ore prices and higher costs.
M impact | EARNINGS | Oct 29, 2026, 11:45 PM UTC
DXC Cuts Fiscal-Year Guidance as Second-Quarter Revenue and Earnings Fall
DXC Technology lowered its current fiscal-year revenue and adjusted earnings forecasts and reported lower revenue and earnings for the second quarter. Its shares fell 13% to $13.25
M impact | EARNINGS | Oct 29, 2026, 11:43 PM UTC
Teck Cuts 2026 Copper Net Cash Unit Cost Guidance to US$1.80–2 per Pound
Teck Resources lowered its 2026 copper net cash unit cost guidance to US$1.80–2 per pound.
M impact | EARNINGS | Oct 29, 2026, 11:37 PM UTC
Mapletree Pan Asia Commercial Trust 2Q Available for Distribution S$103.1M
The trust reported S$103.1 million available for distribution to unitholders in 2Q, versus S$106.2 million.
L impact | EARNINGS | Oct 29, 2026, 11:32 PM UTC
Helix BioPharma Reports FY26 Net Loss of $3.35 Million, Cuts R&D 54%
The company reported a $0.04-per-share loss versus $5.21 million in FY25. R&D spending fell 54% to $1.62 million. Cash was $804,000 and its working capital deficit was $4.18 millio
M impact | EARNINGS | Oct 29, 2026, 11:31 PM UTC